Live healthier, stronger and sharper for longer
Short, frequent pieces on what changed in the science of ageing well — and our research library holds the deep dives.
SupplementsSpermidine & Longevity: Latest Clinical Evidence & Recommendations for 2026
Dive into the cutting-edge clinical evidence on spermidine for longevity, revealing the most recent trial outcomes, updated consensus, and what this means for your healthspan in 2026.
SupplementsCreatine Monohydrate: The Latest Cognitive
New clinical evidence from 2025-2026 reshapes our understanding of creatine monohydrate's cognitive benefits, offering updated recommendations.
SupplementsNMN & Metabolic Health: A 2026 Outlook on
Delve into NMN's potential to improve glucose control, insulin sensitivity, and mitigate metabolic dysfunction, backed by current research and biomarker insights.
PeptidesMOTS-c in the UK: 2026 Outlook for Availability
This deep dive examines the UK availability, legal standing, and cost considerations for MOTS-c, a promising mitochondrial-derived peptide, heading into 2026.
SupplementsUrolithin A in the UK: Availability, Cost, and
Exploring Urolithin A's landscape in the UK, this article details its availability, cost implications, and essential considerations for safe, effective sourcing.
SupplementsOmega-3 (EPA/DHA) in 2026: Latest Clinical
The landscape for Omega-3 (EPA/DHA) supplementation continues to evolve. This deep dive into 2025-2026 evidence uncovers what's truly changed and refines our recommendations.
Wondering where to start?
Two minutes, no blood test, no sign-up — find out how you are actually ageing, and what to do about it.
The Sunday briefing
One email a week: what changed in the evidence, what it means for the markers you track, and the occasional thing worth stopping. No spam, unsubscribe anytime.